It was demonstrated that Setbp1 overexpression activates the HOXA gene signature and Flt3ITD/+/Setbp1IM+ AML is vulnerable to Kdm1a and Brd3 inhibition [29]. Here, SETBP1 is linked to acute myeloid leukemia.